Once a suspect COVID cure, now a right-wing aspirin. As a physician who diagnoses cancer, I have come across this line of ...

U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday.